ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis
June 30, 2020ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European Commission approved it in September 2018. -
Sun Pharma Announces Data Showing Potential of ILUMYA™ to Improve Psoriatic Arthritis Symptoms
June 20, 2019Sun Pharmaceutical announced interim results from a Phase 2 study of interleukin-23 (IL-23) inhibitor ILUMYA™ (tildrakizumab-asmn) in patients with active psoriatic arthritis. The interim analysis revealed that over 71 percent of patients treated with ...
Pharma Sources Insight January 2025
